Cytoskeletal checkpoints, not molecular catalogs, may govern microglial aging: Pfn1 and Arpc4 loss trigger divergent senescence and synaptic deficits.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0035
#Microglia #Cytoskeleton #BrainAging #Dementia
Cytoskeletal checkpoints, not molecular catalogs, may govern microglial aging: Pfn1 and Arpc4 loss trigger divergent senescence and synaptic deficits.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0035
#Microglia #Cytoskeleton #BrainAging #Dementia
Bing Shan & Yaoyang Zhang (CAS) in Cell Chemical Biology
#Epigenetics #RBBP7 #Cancer #Rapamycin
---
epigenometech.com
Bing Shan & Yaoyang Zhang (CAS) in Cell Chemical Biology
#Epigenetics #RBBP7 #Cancer #Rapamycin
---
epigenometech.com
An integrated framework unites target fishing, single-cell multi-omics, and AI reasoning into a closed-loop workflow for natural product target discovery.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0036
#TargetFishing #SingleCellOmics #AIDrugDiscovery
An integrated framework unites target fishing, single-cell multi-omics, and AI reasoning into a closed-loop workflow for natural product target discovery.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0036
#TargetFishing #SingleCellOmics #AIDrugDiscovery
AI pharmacophore-transcriptomic framework repurposes CBD for ischemic stroke via NRF2/BMAL1-mediated antioxidant and angiogenic effects.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0034
#DrugRepurposing #IschemicStroke
AI pharmacophore-transcriptomic framework repurposes CBD for ischemic stroke via NRF2/BMAL1-mediated antioxidant and angiogenic effects.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0034
#DrugRepurposing #IschemicStroke
www.maxapress.com/article/doi/...
www.maxapress.com/article/doi/...
Peroxisomes drive UCP1-independent heat via FASN-ACOX2 cycle, mmBCFA turnover. Cold redistributes FASN, coupling lipid synthesis to energy burn. 🌡️🔬
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0025-0006
#instaenergy #synthesis #energyburn
Peroxisomes drive UCP1-independent heat via FASN-ACOX2 cycle, mmBCFA turnover. Cold redistributes FASN, coupling lipid synthesis to energy burn. 🌡️🔬
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0025-0006
#instaenergy #synthesis #energyburn
AI-designed evodiamine derivative 8a targets gp130, halting tumor growth by 56%! Novel indolopyridine offers promising colorectal cancer therapy breakthrough.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0010
#cancertherapy #tumor #therapy
AI-designed evodiamine derivative 8a targets gp130, halting tumor growth by 56%! Novel indolopyridine offers promising colorectal cancer therapy breakthrough.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0010
#cancertherapy #tumor #therapy
New study in Nature Neuroscience reveals Fc effector function is crucial for lecanemab's amyloid clearance in Alzheimer's treatment.🧠✨
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0004
#alzheimer #naturelovers #neuroscience #effector
New study in Nature Neuroscience reveals Fc effector function is crucial for lecanemab's amyloid clearance in Alzheimer's treatment.🧠✨
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0004
#alzheimer #naturelovers #neuroscience #effector
Degradation-based protein profiling (DBPP) leverages PROTAC technology to convert binding events into amplified depletion signals, enabling target ID of elusive natural products.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0019
#DBPP #PROTAC #DrugDiscovery
Degradation-based protein profiling (DBPP) leverages PROTAC technology to convert binding events into amplified depletion signals, enabling target ID of elusive natural products.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0019
#DBPP #PROTAC #DrugDiscovery
INKT cells uniquely bridge innate/adaptive immunity via CD1d/glycolipid recognition, offering promising off-the-shelf therapy for cancer/infections with low GVHD risk! 🧬💉
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0025-0010
#recognition #therapy #infections
INKT cells uniquely bridge innate/adaptive immunity via CD1d/glycolipid recognition, offering promising off-the-shelf therapy for cancer/infections with low GVHD risk! 🧬💉
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0025-0010
#recognition #therapy #infections
A #Letter by Mei et al. 👇
📖 nph.onlinelibrary.wiley.com/doi/10.1111/...
#LatestIssue
A #Letter by Mei et al. 👇
📖 nph.onlinelibrary.wiley.com/doi/10.1111/...
#LatestIssue
Natural products as multi-target graft protectants: pairing nanocarrier delivery with machine perfusion to curb reperfusion injury in donor heart preservation.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0039
#HeartTransplant #GraftPreservation #Nanocarrier
Natural products as multi-target graft protectants: pairing nanocarrier delivery with machine perfusion to curb reperfusion injury in donor heart preservation.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0039
#HeartTransplant #GraftPreservation #Nanocarrier
(2/2)
#ChemSky #ChemBio #ChemPro #ProteoProbes #ChemicalProteomics
(2/2)
#ChemSky #ChemBio #ChemPro #ProteoProbes #ChemicalProteomics
#Drug repurposing #Deep learning
Details: doi.org/10.48130/tar...
#Drug repurposing #Deep learning
Details: doi.org/10.48130/tar...
#Mitophagy #Cathepsin S
Details: doi.org/10.48130/tar...
#Mitophagy #Cathepsin S
Details: doi.org/10.48130/tar...
The in-solution measurement on #NanoTemper Monolith X means biomolecules retain conformations for these studies
#biophysics
www.tandfonline.com/doi/full/10....
The in-solution measurement on #NanoTemper Monolith X means biomolecules retain conformations for these studies
#biophysics
www.tandfonline.com/doi/full/10....
CLDN18.2 emerges as a promising PDAC therapeutic target, with monoclonal antibodies, bispecific antibodies, CAR-T cell therapy, and antibody-drug conjugates showing clinical progress.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0033
#CLDN18.2 #TargetedTherapy
CLDN18.2 emerges as a promising PDAC therapeutic target, with monoclonal antibodies, bispecific antibodies, CAR-T cell therapy, and antibody-drug conjugates showing clinical progress.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0033
#CLDN18.2 #TargetedTherapy
#Treprostinil #Microparticles
Details: doi.org/10.48130/tar...
#Treprostinil #Microparticles
Details: doi.org/10.48130/tar...
Cardiac mechanical load suppresses tumor growth via Nesprin-2-mediated LINC complex triggering H3K9me3 loss and growth-inhibitive chromatin remodeling.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0032
#Nesprin2 #MechanicalLoad #EpigeneticRemodeling
Cardiac mechanical load suppresses tumor growth via Nesprin-2-mediated LINC complex triggering H3K9me3 loss and growth-inhibitive chromatin remodeling.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0032
#Nesprin2 #MechanicalLoad #EpigeneticRemodeling